{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:22:19Z","timestamp":1782512539067,"version":"3.54.5"},"reference-count":0,"publisher":"Portico","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2013.49.6.1965099","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T09:15:04Z","timestamp":1684228504000},"page":"363","source":"Crossref","is-referenced-by-count":14,"title":["Canagliflozin for the treatment of type 2 diabetes"],"prefix":"10.3730","volume":"49","author":[{"family":"Babu, A.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2013]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:19:27Z","timestamp":1685452767000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dcw4bg"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2013.49.6.1965099","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}